特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
404485

乳癌診断検査:医療機器のパイプライン評価

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 420 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
乳癌診断検査:医療機器のパイプライン評価
出版日: 2020年10月31日
発行: GlobalData
ページ情報: 英文 420 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の乳癌診断検査の関連市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 乳癌診断検査の概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 乳癌診断検査:各企業で現在治験中のパイプライン製品

  • 乳癌診断検査の企業:治験段階別のパイプライン製品
  • 乳癌診断検査:治験段階別のパイプライン製品

第5章 乳癌診断検査の企業・製品の概要

  • A&G Pharmaceutical Inc
  • Abbott Diagnostics
  • Abviva, Inc.
  • Accelerated Medical Diagnostics
  • Acobiom
  • Affichem SA
  • AIT Austrian Institute of Technology GmbH
  • Albert-Ludwigs-Universitat Freiburg
  • Almac Diagnostics Ltd
  • Amarantus Bioscience Holdings Inc
  • AngioGenex Inc
  • Anixa Diagnostics Corporation
  • Armune BioScience, Inc.
  • Arno Therapeutics Inc
  • ArtemixRx
  • Ascendant Diagnostics, LLC
  • Assurance Biosciences, Inc. (Inactive)
  • Atossa Genetics, Inc.
  • Aurelium BioPharma Inc.
  • Autoimmune Technologies LLC
  • Ayanda Biosystems SA (Inactive)
  • Baylor College of Medicine
  • BCAL Diagnostics Pty Limited
  • Becton Dickinson and Company
  • Biocartis SA Company Overview
  • Biocrates Life Sciences AG
  • Biodesix Inc
  • BioMarCare Technologies Ltd.
  • BioMark Diagnostics Inc.
  • BioMarker Strategies LLC
  • bioMerieux S.A.
  • Biomoda, Inc. (Inactive)
  • Biosceptre (Aust) Pty Ltd
  • BioSystems International
  • Bio-Techne Corp
  • bioTheranostics Inc
  • BioTime Inc
  • Caprion Biosciences Inc
  • Cellanyx Diagnostics, Inc.
  • CellMax Life
  • CellXplore, Inc.
  • Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco
  • Cepheid
  • Ceres Nanosciences Inc
  • Cernostics Inc.
  • China Sky One Medical Inc
  • Chronix Biomedical Inc
  • Clarient Inc
  • Cleveland Diagnostics Inc.
  • CompanDX Ltd.
  • Courtagen Life Sciences Inc
  • CS-Keys, Inc.
  • Da An Gene Co Ltd
  • Dana-Farber Cancer Institute Inc
  • Dartmouth College
  • Diaxonhit SA
  • Dublin City University
  • Emergence BioScreening, LLC
  • Eventus Diagnostics Inc (Inactive)
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fahy Gurteen UK Ltd
  • Fina Biotech
  • Fluxion Biosciences, Inc.
  • Fournira Optime Diagnostics
  • French National Institute of Health and Medical Research
  • GeneNews Ltd
  • Genentech Inc
  • GenomicTree Inc
  • Genoptix Inc
  • George Washington University
  • German Cancer Research Center
  • Ghent University
  • GlycoZym
  • H. Lee Moffitt Cancer Center & Research Institute Inc
  • Hai Kang Life Corp Ltd
  • Health Discovery Corp
  • Hebrew University of Jerusalem
  • Heragen, Inc.
  • Hummingbird Diagnostics GmbH
  • Ikonisys Inc
  • IncellDx Inc
  • Innovative Health Diagnostics
  • Insight Genetics Inc
  • Institute of Cancer Research
  • Inverness Medical Canada Inc. (Inactive)
  • IRIS International, Inc.
  • ITUS Corporation
  • IV Diagnostics, Inc.
  • John Hopkins University
  • Jonakee Cancer Research, Inc.
  • Kailos Genetics, Inc.
  • Kalgene Pharmaceuticals Inc.
  • Leica Biosystems GmbH
  • Louisville Bioscience, Inc.
  • MabCure Inc.
  • Matrix-Bio, Inc.
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • Medical Prognosis Institute A/S
  • MEDITE Cancer Diagnostics Inc
  • MedMira Inc.
  • Metabolomic Technologies Inc
  • MetaStat Inc
  • Milagen, Inc.
  • MiRXES Pte Ltd
  • Molecular Warehouse Ltd
  • Myriad Genetics Inc
  • NanoString Technologies Inc
  • National University of Ireland, Galway
  • New York University
  • Newcastle University
  • Novel Bio-spectrum Technologies, Inc.
  • Nuclea Biotechnologies Inc. (Inactive)
  • Nuvera Biosciences Inc
  • Olink Proteomics AB
  • Olympia Diagnostics, Inc
  • Onconome, Inc. (Inactive)
  • OncoStem Diagnostics Pvt. Ltd
  • OncoVista Innovative Therapies Inc
  • On-Q-ity, Inc. (Inactive)
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Impedance Diagnostics Ltd
  • PeriRx LLC
  • Power3 Medical Products, Inc.
  • Precision Biologics Inc
  • PreMD Inc
  • Princeton University
  • Proplex Technologies Llc
  • Protagen AG
  • Proteome Sciences Plc
  • Proteomika
  • Provista Diagnostics Inc.
  • Qiagen NV
  • Quest Diagnostics Inc
  • Rna Diagnostics Inc.
  • Roche Diagnostics International Ltd
  • Rosetta Genomics Ltd
  • Royal College of Surgeons in Ireland
  • RWTH Aachen University
  • Savicell Diagnostic Ltd.
  • Selventa Inc
  • Sengenics International Pte Ltd
  • Siamab Therapeutics Inc
  • Siemens Healthcare GmbH
  • Soricimed Biopharma Inc
  • Target Discovery, Inc.
  • Taxor Diagnostics, LLC
  • TechnoGenesys, Inc.
  • The University of Texas MD Anderson Cancer Center
  • Todos Medical
  • Trinity College Dublin
  • Universal Diagnostics, S. L.
  • Universite De Lyon
  • University of Alberta
  • University of Bonn
  • University of California Riverside
  • University of California San Diego
  • University of Chicago
  • University of Colorado
  • University of Iowa
  • University of Maryland, Baltimore
  • University of Nebraska
  • University of Oxford
  • University of South Florida
  • University of Wisconsin Madison
  • US Biomarkers Inc
  • Vermillion Inc
  • Viomics Inc.
  • Vitatex Inc.
  • Vitruvian Biomedical, Inc.
  • VolitionRX Ltd
  • XEPTAGEN SpA
  • Xiamen Zeesan Biotech Co.,Ltd
  • Zetiq Technologies Ltd

第6章 乳癌診断検査市場:昨今の動向 (全46件)

第7章 提言

図表一覧

図表

List of Tables

List of Tables

  • Table 1: Breast Cancer - Pipeline Products by Stage of Development
  • Table 2: Breast Cancer - Pipeline Products by Territory
  • Table 3: Breast Cancer - Pipeline Products by Regulatory Path
  • Table 4: Breast Cancer - Pipeline Products by Estimated

List of Figures

List of Figures

  • Figure 1: Breast Cancer - Pipeline Products by Stage of Development
  • Figure 2: Breast Cancer - Pipeline Products by Territory
  • Figure 3: Breast Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Breast Cancer - Pipeline Products by Estimated Approval Date
  • Figure 5: Breast Cancer - Ongoing Clinical Trials
目次
Product Code: GDME1024EPD

GlobalData's Medical Devices sector report, "Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Breast Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient's sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Breast Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Breast Cancer Overview

3 Products under Development

  • 3.1 Breast Cancer - Pipeline Products by Stage of Development
  • 3.2 Breast Cancer - Pipeline Products by Territory
  • 3.3 Breast Cancer - Pipeline Products by Regulatory Path
  • 3.4 Breast Cancer - Pipeline Products by Estimated Approval Date
  • 3.5 Breast Cancer - Ongoing Clinical Trials

4 Breast Cancer - Pipeline Products under Development by Companies

  • 4.1 Breast Cancer Companies - Pipeline Products by Stage of Development
  • 4.2 Breast Cancer - Pipeline Products by Stage of Development

5 Breast Cancer Companies and Product Overview

6 Breast Cancer- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.